A V Hoffbrand1, D G Weir. Show Affiliations » 1. Department of Haematology, Royal Free Hampstead NHS Trust, London, UK. v.hoffbrand@rfc.ucl.ac.uk
Abstract
Entities: Chemical
Mesh: See more » Anemia/drug therapyAnemia/historyBrain Diseases/etiologyBrain Diseases/historyColonic Neoplasms/drug therapyColonic Neoplasms/etiologyColonic Neoplasms/historyFemaleFolic Acid/historyFolic Acid/therapeutic useFolic Acid Deficiency/drug therapyFolic Acid Deficiency/historyHistory, 20th CenturyHumansHyperhomocysteinemia/complicationsHyperhomocysteinemia/historyMethotrexate/historyMethotrexate/therapeutic useNeural Tube Defects/etiologyNeural Tube Defects/historyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/historyPregnancyPregnancy Complications, Hematologic/drug therapyVascular Diseases/etiologyVascular Diseases/historyVitamin B 12 Deficiency/complicationsVitamin B 12 Deficiency/history
Substances: See more » Folic AcidMethotrexate
Year: 2001 PMID: 11380441 DOI: 10.1046/j.1365-2141.2001.02822.x
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998